Professor Andrew Finlay has led the development of quality of life outcome measures in dermatology for over three decades. He and colleagues created the most widely used outcome measures in dermatology worldwide, the Dermatology Life Quality Index (DLQI), and for children, the CDLQI. Recent research includes measuring the impact of all diseases on family members of patients, validating e-delivery of quality of life measurement and exploring the influences on outpatient discharge decisions.
Prof Finlay was previously Head of the Department of Dermatology, Cardiff University, Cardiff, UK. He created the international e-learning Diploma In Practical Dermatology. He was President of the British Association of Dermatologists, represented the UK on the Union of European Medical Specialists dermatology committee and has recently chaired the Executive Committee of the UK Dermatology Clinical Trials Network. Author of over 385 publications, he is co-authoring the second edition of the undergraduate dermatology textbook “Dermatology at a Glance”.
He was appointed CBE in 2010 and has been awarded the 2018 British Society for Investigative Dermatology Medal, the Herman Musaph Foundation Award and Medal and the Austrian Society of Dermatology Hebra Medal.
Major research theme: the development of techniques to measure disability caused by skin disease. Dermatology and disease specific questionnaires created and validated to measure quality of life, including PDI, DLQI, CDLQI, FDLQI, CADI, PFI, DFI, IDQoL, T-QoL and FROM-16. These techniques are used widely internationally. Further research area: influences on medical decision taking.